-
ANH News Beat (week 40/2023)
04 October 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 43/2023)
26 October 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH-USA study finds 'forever chemicals' in kale
28 June 2023
Our US team at Alliance for Natural Health USA tested the US FDA's claim that the majority of the US food supply was free from PFAS 'forever chemicals' - and guess what we found?
News / Food4Health Campaign / Health / Food / Activism
-
PFAS campaign airs Down Under
20 July 2023
ANH founder, Rob Verkerk PhD joined Australian TNT Radio presenter, Dean Mackin, to discuss ANH-USA's PFAS in kale report and why PFAS chemicals pose such a serious threat to humanity and the environment
-
ANH News Beat (week 16/2023)
20 April 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 15/2023)
13 April 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Peptide bioregulators presentation
18 July 2023
This presentation on peptide bioregulators is available to all Pathfinder members with an interest in their mechanisms and how they might help support our overall health
-
Is the semi-natural sweetener erythritol as bad as aspartame?
16 March 2023
ANH-USA's medical director, Ron Hoffman MD, examines a new study suggesting low-carb sweetener erythritol increases heart attack risk - all is not as the headlines profess!
News / Food4Health Campaign / Health / Food / Campaigns
-
Build your brain’s resilience with BDNF
30 March 2023
Find out which nutrition and lifestyle choices will help you keep an agile, flexible and fully functioning brain throughout your life
-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’